Unphosphorylated STAT3 regulates the antiproliferative, antiviral, and gene-inducing actions of type I interferons

Biochemical and Biophysical Research Communications

Volumn 490, Issue 3, 2017, Pages 739-745

  Pfeffer, Susan R ^a   Fan, Meiyun ^a   Du, Ziyun ^a   Yang, Chuan He ^a   Pfeffer, Lawrence M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Antiproliferative; Antiviral; Gene expression; Interferon; STAT

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON; MUTANT PROTEIN; STAT3 PROTEIN; TYROSINE; ANTIVIRUS AGENT; PROTEIN BINDING;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYO; GENE INDUCTION; GERM LINE; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; VIRUS INHIBITION; ANIMAL; CELL LINE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; FIBROBLAST; GENE INACTIVATION; GENETICS; METABOLISM; PHOSPHORYLATION; TRANSCRIPTION INITIATION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CELL PROLIFERATION; FIBROBLASTS; GENE KNOCKOUT TECHNIQUES; INTERFERON TYPE I; MICE; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION;

EID: 85021222101     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2017.06.111     Document Type: Article

References (26)

1. Meraz, M.A., White, J.M., Sheehan, K.C., Bach, E.A., Rodig, S.J., Dighe, A.S., Kaplan, D.H., Riley, J.K., Greenlund, A.C., Campbell, D., Carver-Moore, K., DuBois, R.N., Clark, R., Aguet, M., Schreiber, R.D., Targeted disruption of the Stat1 gene in mice reveals unexpected physiological specificity in the JAK-STAT signaling pathway. Cell 84 (1996), 431–442.
2. Darnell, J.E.J., Kerr, I.M., Stark, G.R., Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264 (1994), 1415–1421.
3. Akira, S., Nishio, Y., Inoue, M., Wang, X.-J., Wei, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., Kishimoto, T., Molecular Cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77 (1994), 63–71.
4. Zhong, Z., Wen, Z., Darnell, J.E.J., Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264 (1994), 95–98.
5. Yang, C.H., Shi, W., Basu, L., Murti, A., Constantinescu, S.N., Blatt, L., Croze, E., Mullersman, J.E., Pfeffer, L.M., Direct association of STAT3 with the IFNAR1 signal transducing chain of the type I IFN receptor. J. Biol. Chem. 271 (1996), 8057–8061.
6. Yang, J., Chatterjee-Kishore, M., Staugaitis, S.M., Nguyen, H., Schlessinger, K., Levy, D.E., Stark, G.R., Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation. Cancer Res. 65 (2005), 939–947.
7. Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., Akira, S., Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 94 (1997), 3801–3804.
8. Wegrzyn, J., Potla, R., Chwae, Y.J., Sepuri, N.B., Zhang, Q., Koeck, T., Derecka, M., Szczepanek, K., Szelag, M., Gornicka, A., Moh, A., Moghaddas, S., Chen, Q., Bobbili, S., Cichy, J., Dulak, J., Baker, D.P., Wolfman, A., Stuehr, D., Hassan, M.O., Fu, X.Y., Avadhani, N., Drake, J.I., Fawcett, P., Lesnefsky, E.J., Larner, A.C., Function of mitochondrial Stat3 in cellular respiration. Science 323 (2009), 793–797.
9. Levy, D.E., Darnell, J.E. Jr., Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3 (2002), 651–662.
10. Yu, H., Jove, R., The STATs of cancer–new molecular targets come of age. Nat. Rev. Cancer 4 (2004), 97–105.
11. Bromberg, J.F., Darnell, J.E. Jr., Potential roles of Stat1 and Stat3 in cellular transformation. Cold Spring Harb. Symp. Quant. Biol. 64 (1999), 425–428.
12. Grandis, J.R., Drenning, S.D., Zeng, Q., Watkins, S.C., Melhem, M.F., Endo, S., Johnson, D.E., Huang, L., He, Y., Kim, J.D., Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 4227–4232.
13. Xu, Q., Briggs, J., Park, S., Niu, G., Kortylewski, M., Zhang, S., Gritsko, T., Turkson, J., Kay, H., Semenza, G.L., Cheng, J.Q., Jove, R., Yu, H., Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene 24 (2005), 5552–5560.
14. Pfeffer, L.M., Mullersman, J.E., Pfeffer, S.R., Murti, A., Shi, W., Yang, C.H., STAT3 as an adapter to couple phosphatidylinositol-3 kinase to the IFNAR-1 chain of the type I IFN receptor. Science 276 (1997), 1418–1420.
15. Yang, C.H., Murti, A., Pfeffer, L.M., STAT3 complements defects in an interferon-resistant cell line: evidence for an essential role for STAT3 in interferon signaling and biological activities. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 5568–5572.
16. Yang, C.H., Wei, L., Pfeffer, S.R., Du, Z., Murti, A., Valentine, W.J., Zheng, Y., Pfeffer, L.M., Identification of CXCL11 as a STAT3-dependent gene induced by IFN. J. Immunol. 178 (2007), 986–992.
17. Arduini, R.M., Li, Z., Rapoza, A., Gronke, R., Hess, D.M., Wen, D., Miatkowski, K., Coots, C., Kaffashan, A., Viseux, N., Delaney, J., Domon, B., Young, C.N., Boynton, R., Chen, L.L., Chen, L., Betzenhauser, M., Miller, S., Gill, A., Pepinsky, R.B., Hochman, P.S., Baker, D.P., Expression, purification, and characterization of rat interferon-beta, and preparation of an N-terminally PEGylated form with improved pharmacokinetic parameters. Protein Expr. Purif. 34 (2004), 229–242.
18. Debidda, M., Wang, L., Zang, H., Poli, V., Zheng, Y., A role of STAT3 in Rho GTPase-regulated cell migration and proliferation. J. Biol. Chem. 280 (2005), 17275–17285.
19. Pfeffer, L.M., Kim, J.G., Pfeffer, S.R., Carrigan, D.J., Baker, D.P., Wei, L., Homayouni, R., The role of NF-κB in the antiviral action of interferon and interferon-regulated gene expression. J. Biol. Chem. 279 (2004), 31304–31311.
20. Eisenkraft, B.L., Nanus, D.M., Albino, A.P., Pfeffer, L.M., a-Interferon down-regulates epidermal growth factor receptors on renal carcinoma cells: relation to cellular responsiveness to the antiproliferative action of a-interferon. Cancer Res. 51 (1991), 5881–5887.
21. Nowak, D.E., Tian, B., Brasier, A.R., Two-step cross-linking method for identification of NF-kappaB gene network by chromatin immunoprecipitation. Biotechniques 39 (2005), 715–725.
22. Wei, L., Fan, M., Xu, L., Heinrich, K., Berry, M.W., Homayouni, R., Pfeffer, L.M., Bioinformatic analysis reveals cRel as a regulator of a subset of interferon-stimulated genes. J. Interferon Cytokine Res. 28 (2008), 541–551.
23. Wei, L., Sandbulte, M.R., Thomas, P.G., Webby, R.J., Homayouni, R., Pfeffer, L.M., NFκB negatively regulates interferon-induced gene expression and anti-influenza activity. J. Biol. Chem. 281 (2006), 11678–11684.
24. Squarize, C.H., Castilho, R.M., Sriuranpong, V., Pinto, D.S. Jr., Gutkind, J.S., Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma. Neoplasia 8 (2006), 733–746.
25. Lee, H., Herrmann, A., Deng, J.H., Kujawski, M., Niu, G., Li, Z., Forman, S., Jove, R., Pardoll, D.M., Yu, H., Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell 15 (2009), 283–293.
26. Yang, J., Liao, X., Agarwal, M.K., Barnes, L., Auron, P.E., Stark, G.R., Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev. 21 (2007), 1396–1408.